Short Summary
MediaTek successfully petitioned to challenge 18 claims of MOSAID's patent (8854077) based on obviousness. The PTAB ruled in favor of institution, finding multiple grounds combining prior art references like Takahashi and Mizuno render the claims unpatentable.
Detailed Summary
Petitioner MediaTek Inc. challenged Patent No. 8854077 owned by MOSAID Technologies Inc., asserting that all 18 claims are obvious under 35 U.S.C. § 103. The petition presented several grounds, including combinations of Takahashi with Ko and Schutz, and Mizuno combined with Ko. The PTAB ultimately found that the advanced bionics and Becton factors favored institution, meaning the patent owner's claims were deemed sufficiently challenged to proceed to a hearing.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in MediaTek Inc. et al. vs MOSAID Technologies Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Hecht, ThomasvsCarver Edison, Inc.
Petitioner Thomas Hecht filed an IPR challenging 18 claims of U.S. Patent No. 10,445,833, arguing the methods for maximizing ESPP shares are obvious over prior art combining financial and computer technology.
Bose CorporationvsIngenioSpec, LLC
Court decision.
Bose CorporationvsIngenioSpec, LLC
Court decision.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
The PTAB held that most of the claims of Netlist’s ’907 memory‑module patent were obvious over the Ellsberry reference (and its combinations), cancelling 63 of 65 challenged claims. Claims 40 and 41 survived. Samsung emerged as the prevailing challenger.
AZURITY PHARMACEUTICALS, INC.vsHelsinn Healthcare S.A.
AZURITY PHARMACEUTICALS successfully convinced the PTAB that multiple claims of Helsinn Healthcare's anti-emetic patent were unpatentable. The Board granted institution based on obviousness (103) over several prior art references, paving the way for a full trial.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.